J.J. Nair et al. / Phytochemistry 66 (2005) 373–382
381
ml) and extracted with EtOAc (3 · 5 ml). The combined
organic fractions were then dried over anhydrous
MgSO4, filtered and the solvent removed under reduced
pressure to yield a crude gum (15 mg) which was purified
by prep. TLC [MeOH/EtOAc (2:3)] to give ambelline
(5.8 mg, 95%) as white crystals from Me2CO (Viladomat
et al., 1994, 1995).
4.11. Synthesis of 11-O-methanesulphonylambelline (10)
Ambelline (20 mg, 60.4 lmol) and 4-N,N-dimethyla-
minopyridine (DMAP) (0.74 mg, 6.04 lmol) were dis-
solved at rt in CH2Cl2 (1 ml) to which pyridine (9.8
ll, 120.8 lmol) was added. After 15 min methanesul-
phonyl chloride (9.8 ll, 120.8 lmol) was introduced
and the solution stirred at 40 ꢁC. After TLC [MeOH/
EtOAc (2:3)] indicated the reaction to be complete (4
h) the mixture was diluted with water (5 ml) and ex-
tracted with CH2Cl2 (3 · 5 ml). The combined organic
fractions were then dried over anhydrous MgSO4, fil-
tered and the solvent removed under reduced pressure
to yield a crude gum (30 mg) which was purified by
prep. TLC [MeOH/EtOAc (2:3)] to give 11-O-methane-
sulphonylambelline (10) (23.7 mg, 96%) as white crys-
tals from Me2CO. Found: C, 55.47; H, 5.41; N, 3.32.
C19H23NSO7 requires: C, 55.73; H, 5.66; N, 3.42%.
4.10. Synthesis of 11-O-benzoylambelline (9)
Sodium hydride (60% suspension in mineral oil) (4.8
mg, 120.8 lmol) was added to a solution of ambelline
(20 mg, 60.4 lmol) in 1 ml DMF and the mixture stirred
at rt for 20 min, then cooled to 0 ꢁC and benzoyl chlo-
ride (17.0 mg, 120.8 lmol) introduced and the solution
allowed to warm to rt. After TLC [MeOH/EtOAc
(2:3)] indicated the reaction to be complete (6 h) the mix-
ture was diluted with water (5 ml) and extracted with
CH2Cl2 (3 · 5 ml). The combined organic fractions were
then dried over anhydrous MgSO4, filtered and the sol-
vent removed under reduced pressure to yield a crude
gum (34 mg) which was purified by prep. TLC
[MeOH/EtOAc (2:3)] to give 11-O-benzoylambelline
(9) (25.5 mg, 97%) as white crystals from Me2CO.
Found: C, 68.36; H, 5.58; N, 2.99. C25H25NO6
requires: C, 68.95; H, 5.79; N, 3.22%. Mp 118–120 ꢁC.
20
20
Mp 98–100 ꢁC. ½aꢁ þ4:1 ðCHCl3; c 0:565Þ; CD½hꢁk :
D
½hꢁ
þ603, [h]286 –631 (MeOH; c 0.05). IR mmax
253
cmꢀ1: 2925, 1618, 1500, 1479, 1402, 1356 (O@S@O),
1282, 1215, 1176, 1130, 1086, 1045 (C–O), 953, 934
(OCH2O), 757. EIMS 70 eV, m/z (rel. int.): 409 [M]+
(34), 394 [M ꢀ CH3]+ (1), 378 [M ꢀ CH3–O]+ (2), 330
[M ꢀ CH3–SO2]+ (41), 313 (100), 298 (41), 282 (48),
1
270 (80), 254 (51), 240 (53), 215 (24). H NMR spectral
data (500 MHz, CDCl3): d 1.67 (1H, ddd, J = 14.0,
13.6, 4.0 Hz, H-4b), 2.21 (1H, ddd, J = 14.0, 4.0, 2.0
Hz, H-4a), 2.88 (3H, s, S-CH3), 2.91 (1H, dd,
J = 14.0, 4.0 Hz, H-12endo), 3.35 (3H, s, 3-OCH3),
3.49 (1H, dd, J = 13.6, 4.0 Hz, H-4a), 3.85 (1H, ddd,
J = 5.6, 4.0, 2.0 Hz, H-3), 3.86 (1H, dd, J = 14.0, 8.4
Hz, H-12exo), 3.93 (1H, d, J = 17.6 Hz, H-6b), 3.99
(3H, s, 7-OCH3), 4.36 (1H, d, J = 17.6 Hz, H-6a),
5.14 (1H, dd, J = 8.4, 4.0 Hz, H-11exo), 5.87-5.90
(2H, 2d, J = 1.4 Hz, OCH2O), 6.10 (1H, dd, J = 10.4,
5.6 Hz, H-2), 6.57 (1H, s, H-10), 6.58 (1H, d,
J = 10.4 Hz, H-1). 13C NMR spectral data (75 MHz,
CDCl3): d 28.8 (t, C-4), 38.4 (q, S-CH3), 47.0 (s, C-
10b), 56.9 (q, 3-OCH3), 59.3 (q, 7-OCH3), 59.4 (t, C-
6), 59.5 (t, C-12), 63.5 (d, C-4a), 72.1 (d, C-3), 91.5
(d, C-11), 100.2 (d, C-10), 101.0 (t, OCH2O), 117.0 (s,
C-6a), 127.8 (d, C-2), 130.3 (d, C-1), 132.3 (s, C-10a),
134.4 (s, C-8), 140.8 (s, C-7), 148.3 (s, C-9).
2 0
2 0
½aꢁ þ25:8 ðCHCl3; c 0:295Þ; CD½hꢁk : ½hꢁ
ꢀ 6746,
D
2 47
[h]286 +2024 (MeOH; c 0.02). IR mmax cmꢀ1: 2925, 1716
(>C@O), 1617, 1477, 1401, 1315, 1277, 1217, 1086,
1072, 1046 (C–O), 978, 933 (OCH2O), 756. EIMS 70
eV, m/z (rel. int.): 435 [M]+ (23), 420 [M ꢀ CH3]+ (2),
330 [M ꢀ PhCO]+ (4), 313 (54), 298 (21), 282 (21), 270
(8), 254 (30), 240 (22), 227 (6), 211 (11), 105 [PhCO]+
(100), 77 [C6H5]+ (57). 1H NMR spectral data (500
MHz, CDCl3): d 1.82 (1H, ddd, J = 14.0, 13.6, 4.0 Hz,
H-4b), 2.42 (1H, ddd, J = 14.0, 4.0, 2.0 Hz, H-4a), 2.92
(1H, dd, J = 14.0, 4.0 Hz, H-12endo), 3.38 (3H, s, 3-
OCH3), 3.65 (1H, dd, J = 13.6, 4.0 Hz, H-4a), 3.90
(1H, ddd, J = 5.0, 4.0, 2.0 Hz, H-3), 4.01 (3H, s, 7-
OCH3), 4.03 (1H, d, J = 17.2 Hz, H-6b), 4.08 (1H, dd,
J = 14.0, 8.0 Hz, H-12exo), 4.47 (1H, d, J = 17.2 Hz,
H-6a), 5.37 (1H, dd, J = 8.0, 4.0 Hz, H-11exo), 5.81–
5.86 (2H, 2d, J = 1.2 Hz, OCH2O), 6.11 (1H, dd,
J = 10.0, 5.0 Hz, H-2), 6.55 (1H, s, H-10), 6.58 (1H, d,
J = 10.0 Hz, H-1), 7.35 (2H, d, J = 7.6 Hz, H-40/H-60),
7.51 (1H, t, J = 7.6, 7.2 Hz, H-50), 7.66 (2H, d, J = 7.6
Hz, H-30/H-70). 13C NMR spectral data (75 MHz,
CDCl3): d 28.3 (t, C-4), 47.8 (s, C-10b), 57.0 (q, 3-
OCH3), 58.5 (t, C-6), 59.4 (t, C-12), 59.5 (q, 7-OCH3),
63.8 (d, C-4a), 72.0 (d, C-3), 86.5 (d, C-11), 99.9 (d, C-
10), 101.0 (t, OCH2O), 115.7 (s, C-6a), 124.8 (s, C-20),
127.3 (d, C-2), 128.5 (2d, C-40/C-60), 129.7 (2d, C-30/C-
70), 130.5 (d, C-1), 133.1 (s, C-10a), 133.4 (d, C-50),
134.3 (s, C-8), 141.0 (s, C-7), 148.6 (s, C-9), 166.4 (s,
C-10).
4.12. Biological activity
The anti-protozoal activity screen of filifoline against
the four different parasitic protozoa was carried out in
vitro in parallel with the respective standards: Trypano-
soma cruzi (strain Tulahuen C4, stage trypomastigotes)/
benznidazole std. IC50 = 0.31 lg/ml; Leishmania dono-
vani (strain MHOM-ET-67/L82, stage amastigotes)/mil-
tefosine std. IC50 = 0.19 lg/ml; Plasmodium falciparum
(strain K1, stage IEF)/artemisinin std. IC50 = 0.0018